|
1
|
Lewis EB: A gene complex controlling
segmentation in Drosophila. Nature. 276:565–570. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levine SS, Weiss A, Erdjument-Bromage H,
Shao Z, Tempst P and Kingston RE: The core of the polycomb
repressive complex is compositionally and functionally conserved in
flies and humans. Mol Cell Biol. 22:6070–6078. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sparmann A and van Lohuizen M: Polycomb
silencers control cell fate, development and cancer. Nat Rev
Cancer. 6:846–856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kerppola TK: Polycomb group complexes-many
combinations, many functions. Trends Cell Biol. 19:692–704. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bracken AP, Dietrich N, Pasini D, Hansen
KH and Helin K: Genome-wide mapping of Polycomb target genes
unravels their roles in cell fate transitions. Genes Dev.
20:1123–1136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
James TC, Eissenberg JC, Craig C, Dietrich
V, Hobson A and Elgin SC: Distribution patterns of HP1, a
heterochromatin-associated nonhistone chromosomal protein of
Drosophila. Eur J Cell Biol. 50:170–180. 1989.PubMed/NCBI
|
|
7
|
James TC and Elgin SC: Identification of a
nonhistone chromosomal protein associated with heterochromatin in
Drosophila melanogaster and its gene. Mol Cell Biol. 6:3862–3872.
1986.PubMed/NCBI
|
|
8
|
Desai D and Pethe P: Polycomb repressive
complex 1: Regulators of neurogenesis from embryonic to adult
stage. J Cell Physiol. 235:4031–4045. 2020. View Article : Google Scholar
|
|
9
|
Ma RG, Zhang Y, Sun TT and Cheng B:
Epigenetic regulation by polycomb group complexes: Focus on roles
of CBX proteins. J Zhejiang Univ Sci B. 15:412–428. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Camahort R and Cowan CA: Cbx proteins help
ESCs walk the line between self-renewal and differentiation. Cell
Stem Cell. 10:4–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang B, Tang J, Liao D, Wang G, Zhang M,
Sang Y, Cao J, Wu Y, Zhang R, Li S, et al: Chromobox homolog 4 is
correlated with prognosis and tumor cell growth in hepatocellular
carcinoma. Ann Surg Oncol. 20(Suppl 3): S684–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Kang M, Zhang B, Meng F, Song J,
Kaneko H, Shimamoto F and Tang B: m6A
modification-mediated CBX8 induction regulates stemness and
chemosensitivity of colon cancer via upregulation of LGR5. Mol
Cancer. 18:1852019. View Article : Google Scholar
|
|
13
|
Zhang Y, Chen H, Zhu H and Sun X: CBX8
promotes tumorigenesis and confers radioresistance in esophageal
squamous cell carcinoma cells through targeting APAF1. Gene.
711:1439492019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang Z, Yan Y, Zhu Z, Liu J, He X,
Dalangood S, Li M, Tan M, Cai J, Tang P, et al: CBX7 suppresses
urinary bladder cancer progression via modulating AKR1B10-ERK
signaling. Cell Death Dis. 12:5372021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iqbal MA, Siddiqui S, Ur Rehman A,
Siddiqui FA, Singh P, Kumar B and Saluja D: Multiomics integrative
analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic
reprogramming of breast cancer. Mol Oncol. 15:1450–1465. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsai HC and Baylin SB: Cancer epigenetics:
Linking basic biology to clinical medicine. Cell Res. 21:502–517.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simhadri C, Daze KD, Douglas SF, Quon TT,
Dev A, Gignac MC, Peng F, Heller M, Boulanger MJ, Wulff JE, et al:
Chromodomain antagonists that target the polycomb-group
methyllysine reader protein chromobox homolog 7 (CBX7). J Med Chem.
57:2874–2883. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim KH and Roberts CW: Targeting EZH2 in
cancer. Nat Med. 22:128–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eich ML, Athar M, Ferguson JE III and
Varambally S: EZH2-targeted therapies in cancer: Hype or a reality.
Cancer Res. 80:5449–5458. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Berthon C, Raffoux E, Thomas X, Vey N,
Gomez-Roca C, Yee K, Taussig DC, Rezai K, Roumier C, Herait P, et
al: Bromodomain inhibitor OTX015 in patients with acute leukaemia:
A dose-escalation, phase 1 study. Lancet Haematol. 3:e186–e195.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shorstova T, Marques M, Su J, Johnston J,
Kleinman CL, Hamel N, Huang S, Alaoui-Jamali MA, Foulkes WD and
Witcher M: SWI/SNF-compromised cancers are susceptible to
bromodomain inhibitors. Cancer Res. 79:2761–2774. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeon YH, Kim GW, Kim SY, Yi SA, Yoo J, Kim
JY, Lee SW and Kwon SH: Heterochromatin protein 1: A Multiplayer in
cancer progression. Cancers (Basel). 14:7632022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
German B and Ellis L: Polycomb directed
cell fate decisions in development and cancer. Epigenomes.
6:282022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parreno V, Martinez AM and Cavalli G:
Mechanisms of Polycomb group protein function in cancer. Cell Res.
32:231–253. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dong GJ, Xu JL, Qi YR, Yuan ZQ and Zhao W:
Critical roles of polycomb repressive complexes in transcription
and cancer. Int J Mol Sci. 23:95742022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fonfría-Subirós E, Acosta-Reyes F, Saperas
N, Pous J, Subirana JA and Campos JL: Crystal structure of a
complex of DNA with one AT-hook of HMGA1. PLoS One. 7:e371202012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tardat M, Albert M, Kunzmann R, Liu Z,
Kaustov L, Thierry R, Duan S, Brykczynska U, Arrowsmith CH and
Peters AH: Cbx2 targets PRC1 to constitutive heterochromatin in
mouse zygotes in a parent-of-origin-dependent manner. Mol Cell.
58:157–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Senthilkumar R and Mishra RK: Novel motifs
distinguish multiple homologues of Polycomb in vertebrates:
Expansion and diversification of the epigenetic toolkit. BMC
Genomics. 10:5492009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Levine SS, King IF and Kingston RE:
Division of labor in polycomb group repression. Trends Biochem Sci.
29:478–485. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Francis NJ, Kingston RE and Woodcock CL:
Chromatin compaction by a polycomb group protein complex. Science.
306:1574–1577. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shao Z, Raible F, Mollaaghababa R, Guyon
JR, Wu CT, Bender W and Kingston RE: Stabilization of chromatin
structure by PRC1, a Polycomb complex. Cell. 98:37–46. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fischle W, Wang Y, Jacobs SA, Kim Y, Allis
CD and Khorasanizadeh S: Molecular basis for the discrimination of
repressive methyl-lysine marks in histone H3 by Polycomb and HP1
chromodomains. Genes Dev. 17:1870–1881. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen T and Dent SY: Chromatin modifiers
and remodellers: Regulators of cellular differentiation. Nat Rev
Genet. 15:93–106. 2014. View Article : Google Scholar
|
|
34
|
Kim J and Kingston RE: The CBX family of
proteins in transcriptional repression and memory. J Biosci.
45:162020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jangal M, Lebeau B and Witcher M: Beyond
EZH2: Is the poly-comb protein CBX2 an emerging target for
anti-cancer therapy. Expert Opin Ther Targets. 23:565–578. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kawaguchi T, Machida S, Kurumizaka H,
Tagami H and Nakayama JI: Phosphorylation of CBX2 controls its
nucleosome-binding specificity. J Biochem. 162:343–355. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuzmichev A, Nishioka K, Erdjument-Bromage
H, Tempst P and Reinberg D: Histone methyltransferase activity
associated with a human multiprotein complex containing the
Enhancer of Zeste protein. Genes Dev. 16:2893–2905. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao Z, Zhang J, Bonasio R, Strino F, Sawai
A, Parisi F, Kluger Y and Reinberg D: PCGF homologs, CBX proteins,
and RYBP define functionally distinct PRC1 family complexes. Mol
Cell. 45:344–356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Blackledge NP, Farcas AM, Kondo T, King
HW, McGouran JF, Hanssen L, Ito S, Cooper S, Kondo K, Koseki Y, et
al: Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2
recruitment and polycomb domain formation. Cell. 157:1445–1459.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schuettengruber B, Bourbon HM, Di Croce L
and Cavalli G: Genome regulation by polycomb and trithorax: 70
years and counting. Cell. 171:34–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao R, Wang L, Wang H, Xia L,
Erdjument-Bromage H, Tempst P, Jones RS and Zhang Y: Role of
histone H3 lysine 27 methylation in Polycomb-group silencing.
Science. 298:1039–1043. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kuzmichev A, Jenuwein T, Tempst P and
Reinberg D: Different EZH2-containing complexes target methylation
of histone H1 or nucleosomal histone H3. Mol Cell. 14:183–193.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Plath K, Talbot D, Hamer KM, Otte AP, Yang
TP, Jaenisch R and Panning B: Developmentally regulated alterations
in Polycomb repressive complex 1 proteins on the inactive X
chromosome. J Cell Biol. 167:1025–1035. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ku M, Koche RP, Rheinbay E, Mendenhall EM,
Endoh M, Mikkelsen TS, Presser A, Nusbaum C, Xie X, Chi AS, et al:
Genomewide analysis of PRC1 and PRC2 occupancy identifies two
classes of bivalent domains. PLoS Genet. 4:e10002422008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chan HL and Morey L: Emerging roles for
polycomb-group proteins in stem cells and cancer. Trends Biochem
Sci. 44:688–700. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yu M, Mazor T, Huang H, Huang HT, Kathrein
KL, Woo AJ, Chouinard CR, Labadorf A, Akie TE, Moran TB, et al:
Direct recruitment of polycomb repressive complex 1 to chromatin by
core binding transcription factors. Mol Cell. 45:330–343. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao Z, Lee P, Stafford JM, von
Schimmelmann M, Schaefer A and Reinberg D: An AUTS2-Polycomb
complex activates gene expression in the CNS. Nature. 516:349–354.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Saunders WS, Chue C, Goebl M, Craig C,
Clark RF, Powers JA, Eissenberg JC, Elgin SC, Rothfield NF and
Earnshaw WC: Molecular cloning of a human homologue of Drosophila
heterochromatin protein HP1 using anti-centromere autoantibodies
with anti-chromo specificity. J Cell Sci. 104:573–582. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nielsen AL, Ortiz JA, You J,
Oulad-Abdelghani M, Khechumian R, Gansmuller A, Chambon P and
Losson R: Interaction with members of the heterochromatin protein 1
(HP1) family and histone deacetylation are differentially involved
in transcriptional silencing by members of the TIF1 family. EMBO J.
18:6385–6395. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Paro R and Hogness DS: The Polycomb
protein shares a homologous domain with a
heterochromatin-associated protein of Drosophila. Proc Natl Acad
Sci USA. 88:263–267. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nielsen AL, Oulad-Abdelghani M, Ortiz JA,
Remboutsika E, Chambon P and Losson R: Heterochromatin formation in
mammalian cells: Interaction between histones and HP1 proteins. Mol
Cell. 7:729–739. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lachner M, O'Carroll D, Rea S, Mechtler K
and Jenuwein T: Methylation of histone H3 lysine 9 creates a
binding site for HP1 proteins. Nature. 410:116–120. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Aasland R and Stewart AF: The chromo
shadow domain, a second chromo domain in heterochromatin-binding
protein 1,HP1. Nucleic Acids Res. 23:3168–3173. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Brasher SV, Smith BO, Fogh RH, Nietlispach
D, Thiru A, Nielsen PR, Broadhurst RW, Ball LJ, Murzina NV and Laue
ED: The structure of mouse HP1 suggests a unique mode of single
peptide recognition by the shadow chromo domain dimer. EMBO J.
19:1587–1597. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cowieson NP, Partridge JF, Allshire RC and
McLaughlin PJ: Dimerisation of a chromo shadow domain and
distinctions from the chromodomain as revealed by structural
analysis. Curr Biol. 10:517–525. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Azzaz AM, Vitalini MW, Thomas AS, Price
JP, Blacketer MJ, Cryderman DE, Zirbel LN, Woodcock CL, Elcock AH,
Wallrath LL, et al: Human heterochromatin protein 1α promotes
nucleosome associations that drive chromatin condensation. J Biol
Chem. 289:6850–6861. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Casale AM, Cappucci U, Fanti L and
Piacentini L: Heterochromatin protein 1 (HP1) is intrinsically
required for post-transcriptional regulation of Drosophila Germline
Stem Cell (GSC) maintenance. Sci Rep. 9:43722019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ligresti G, Caporarello N, Meridew JA,
Jones DL, Tan Q, Choi KM, Haak AJ, Aravamudhan A, Roden AC, Prakash
YS, et al: CBX5/G9a/H3K9me-mediated gene repression is essential to
fibroblast activation during lung fibrosis. JCI Insight.
5:e1271112019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tamaru H and Selker EU: A histone H3
methyltransferase controls DNA methylation in Neurospora crassa.
Nature. 414:277–283. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Feldman N, Gerson A, Fang J, Li E, Zhang
Y, Shinkai Y, Cedar H and Bergman Y: G9a-mediated irreversible
epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat
Cell Biol. 8:188–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016.
View Article : Google Scholar :
|
|
63
|
Davis S and Meltzer PS: GEOquery: A bridge
between the Gene Expression Omnibus (GEO) and BioConductor.
Bioinformatics. 23:1846–1847. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Asplund A, Edqvist PH, Schwenk JM and
Pontén F: Antibodies for profiling the human proteome-The Human
Protein Atlas as a resource for cancer research. Proteomics.
12:2067–2077. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Li J, Xu Z, Zhou L and Hu K: Expression
profile and prognostic values of Chromobox family members in human
glioblastoma. Aging (Albany NY). 14:1910–1931. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zheng ZQ, Yuan GQ, Kang NL, Nie QQ, Zhang
GG and Wang Z: Chromobox 7/8 serve as independent indicators for
glioblastoma via promoting proliferation and invasion of glioma
cells. Front Neurol. 13:9120392022. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao SP, Wang F, Yang M, Wang XY, Jin CL,
Ji QK, Li S and Zhao XL: CBX3 promotes glioma U87 cell
proliferation and predicts an unfavorable prognosis. J Neurooncol.
145:35–48. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhang H, Chen W, Fu X, Su X and Yang A:
CBX3 promotes tumor proliferation by regulating G1/S phase via p21
downregulation and associates with poor prognosis in tongue
squamous cell carcinoma. Gene. 654:49–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang X, Zhou W, Zhang Y and Liu Z: CBX3
is a prognostic biomarker correlated with ATR activation and immune
infiltration in head and neck squamous cell carcinoma. Int J Gen
Med. 15:1497–1508. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Guo XH, Zhang JY, Jiao DC, Zhu JJ, Ma YZ,
Yang Y, Xiao H and Liu ZZ: The expression and significance of
chromobox protein homolog 2 in breast cancer. Zhonghua Yi Xue Za
Zhi. 100:130–135. 2020.In Chinese. PubMed/NCBI
|
|
73
|
Zheng S, Lv P, Su J, Miao K, Xu H and Li
M: Overexpression of CBX2 in breast cancer promotes tumor
progression through the PI3K/AKT signaling pathway. Am J Transl
Res. 11:1668–1682. 2019.PubMed/NCBI
|
|
74
|
Chen WY, Zhang XY, Liu T, Liu Y, Zhao YS
and Pang D: Chromobox homolog 2 protein: A novel biomarker for
predicting prognosis and Taxol sensitivity in patients with breast
cancer. Oncol Lett. 13:1149–1156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Piqué DG, Montagna C, Greally JM and Mar
JC: A novel approach to modelling transcriptional heterogeneity
identifies the oncogene candidate CBX2 in invasive breast
carcinoma. Br J Cancer. 120:746–753. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zeng JS, Zhang ZD, Pei L, Bai ZZ, Yang Y,
Yang H and Tian QH: CBX4 exhibits oncogenic activities in breast
cancer via Notch1 signaling. Int J Biochem Cell Biol. 95:1–8. 2018.
View Article : Google Scholar
|
|
77
|
Li X, Gou J, Li H and Yang X:
Bioinformatic analysis of the expression and prognostic value of
chromobox family proteins in human breast cancer. Sci Rep.
10:177392020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Liang YK, Lin HY, Chen CF and Zeng D:
Prognostic values of distinct CBX family members in breast cancer.
Oncotarget. 8:92375–92387. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Chung CY, Sun Z, Mullokandov G, Bosch A,
Qadeer ZA, Cihan E, Rapp Z, Parsons R, Aguirre-Ghiso JA, Farias EF,
et al: Cbx8 Acts Non-canonically with Wdr5 to promote mammary
tumorigenesis. Cell Rep. 16:472–486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mao G, Zheng Y, Lin S, Ma L, Zhou Z and
Zhang S: Bioinformatic analysis of prognostic value, genetic
interaction, and immune infiltration of chromobox family proteins
in breast cancer. Int J Gen Med. 14:9181–9191. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Xie X, Ning Y, Long J, Wang H and Chen X:
Diverse CBX family members as potential prognostic biomarkers in
non-small-cell lung cancer. FEBS Open Bio. 10:2206–2215. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Chang SC, Lai YC, Chen YC, Wang NK, Wang
WS and Lai JI: CBX3/heterochromatin protein 1 gamma is
significantly upregulated in patients with non-small cell lung
cancer. Asia Pac J Clin Oncol. 14:e283–e288. 2018. View Article : Google Scholar
|
|
83
|
Huang J, Zhang W, Lin D, Lian L, Hong W
and Xu Z: Chromobox Homologue 7 acts as a tumor suppressor in both
lung adenocarcinoma and lung squamous cell carcinoma via inhibiting
ERK/MAPK signaling pathway. Evid Based Complement Alternat Med.
2022:49521852022.PubMed/NCBI
|
|
84
|
Zhang C, Chang L, Yao Y, Chao C, Ge Z, Fan
C, Yu H, Wang B and Yang J: Role of the CBX molecular family in
lung adenocarcinoma tumorigenesis and immune infiltration. Front
Genet. 12:7710622021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang Z, Fang Z, Chen G, Liu B, Xu J, Li F,
Li F, Liu H, Zhang H, Sun Y, et al: Chromobox 4 facilitates
tumorigenesis of lung adenocarcinoma through the Wnt/β-catenin
pathway. Neoplasia. 23:222–233. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Liu J, Shen H, Chen X, Ding Y, Wang H, Xu
N and Teng L: Expression and prognostic value of chromobox family
proteins in esophageal cancer. Genes (Basel). 13:15822022.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Fang X, Wang J, Chen J, Zhuang M, Huang T,
Chen Z, Huang Y, Zheng B and Wang X: Identification and validation
of chromobox family members as potential prognostic biomarkers and
therapeutic targets for human esophageal cancer. Front Genet.
13:8513902022. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hou J, Yang Y, Gao H, Ouyang T, Liu Q,
Ding R and Kan H: Systematic investigation of the clinical
significance and prognostic value of the CBXs in esophageal cancer.
Medicine (Baltimore). 101:e308882022. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ueda S, Kanda M, Sato Y, Baba H, Nakamura
S, Sawaki K, Shimizu D, Motoyama S, Fujii T, Kodera Y, et al:
Chromobox 2 expression predicts prognosis after curative resection
of oesophageal squamous cell carcinoma. Cancer Genomics Proteomics.
17:391–400. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Xiao W, Ou C, Qin J, Xing F, Sun Y, Li Z
and Qiu J: CBX8, a novel DNA repair protein, promotes tumorigenesis
in human esophageal carcinoma. Int J Clin Exp Pathol. 7:4817–4826.
2014.PubMed/NCBI
|
|
91
|
Lin H, Lian J, Xia L, Guan G and You J:
CBX3 promotes gastric cancer progression and affects factors
related to immunotherapeutic responses. Cancer Manag Res.
12:10113–10125. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li W, Chen H, Wang Z, Liu J, Lei X and
Chen W: Chromobox 4 (CBX4) promotes tumor progression and stemness
via activating CDC20 in gastric cancer. J Gastrointest Oncol.
13:1058–1072. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
He M, Yue L, Wang H, Yu F, Yu M, Ni P,
Zhang K, Chen S, Duan G and Zhang R: Evaluation of the prognostic
value of CBXs in gastric cancer patients. Sci Rep. 11:123752021.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Ma T, Ma N, Chen JL, Tang FX, Zong Z, Yu
ZM, Chen S and Zhou TC: Expression and prognostic value of
Chromobox family members in gastric cancer. J Gastrointest Oncol.
11:983–998. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lin K, Zhu J, Hu C, Bu F, Luo C, Zhu X and
Zhu Z: Comprehensive analysis of the prognosis for chromobox family
in gastric cancer. J Gastrointest Oncol. 11:932–951. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Fisher RS, Acevedo C, Arzimanoglou A,
Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA,
Glynn M, et al: ILAE official report: A practical clinical
definition of epilepsy. Epilepsia. 55:475–482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chen ZY, Sun SX, Zhu SX and Bu J:
Identification of the roles of chromobox family members in gastric
cancer: A study based on multiple datasets. Biomed Res Int.
2020:53065092020.PubMed/NCBI
|
|
98
|
Zhang YJ, Zhao LY, He X, Yao RF, Lu F, Lu
BN and Pang ZR: CBXs-related prognostic gene signature correlates
with immune microenvironment in gastric cancer. Aging (Albany NY).
14:6227–6254. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Li Q, Fu L, Wu D and Wang J: Prognostic
and immune infiltrates for the Chromobox (CBX) protein family in
human pancreatic adenocarcinoma. J Gastrointest Oncol.
12:2310–2324. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Teng BW, Zhang KD, Yang YH, Guo ZY, Chen
WW and Qiu ZJ: Genome-wide CRISPR-Cas9 screening identifies that
hypoxia-inducible factor-1a-induced CBX8 transcription promotes
pancreatic cancer progression via IRS1/AKT axis. World J
Gastrointest Oncol. 13:1709–1724. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wang H, Zhao W, Wang J and Zhang Z:
Clinicopathological significance of CBX3 in colorectal cancer: An
intensive expression study based on formalin-fixed and
paraffin-embedded tissues. Pathol Int. 72:107–116. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Tang J, Wang G, Zhang M, Li FY, Sang Y,
Wang B, Hu K, Wu Y, Luo R, Liao D, et al: Paradoxical role of CBX8
in proliferation and metastasis of colorectal cancer. Oncotarget.
5:10778–10790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Li Q, Pan Y, Cao Z and Zhao S:
Comprehensive analysis of prognostic value and immune infiltration
of chromobox family members in colorectal cancer. Front Oncol.
10:5826672020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhou H, Xiong Y, Liu Z, Hou S and Zhou T:
Expression and prognostic significance of CBX2 in colorectal
cancer: Database mining for CBX family members in malignancies and
vitro analyses. Cancer Cell Int. 21:4022021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Yuan GJ, Chen X, Lu J, Feng ZH, Chen SL,
Chen RX, Wei WS, Zhou FJ and Xie D: Chromobox homolog 8 is a
predictor of muscle invasive bladder cancer and promotes cell
proliferation by repressing the p53 pathway. Cancer Sci.
108:2166–2175. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhou J, Chen Z, Zou M, Wan R, Wu T, Luo Y,
Wu G, Wang W and Liu T: Prognosis and immune infiltration of
chromobox family genes in sarcoma. Front Oncol. 11:6575952021.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ma C, Nie XG, Wang YL, Liu XH, Liang X,
Zhou QL and Wu DP: CBX3 predicts an unfavorable prognosis and
promotes tumorigenesis in osteosarcoma. Mol Med Rep. 19:4205–4212.
2019.PubMed/NCBI
|
|
108
|
Yang J, Cheng D, Zhu B, Zhou S, Ying T and
Yang Q: Chromobox Homolog 4 is positively correlated to tumor
growth, survival and activation of HIF-1α signaling in human
osteosarcoma under normoxic condition. J Cancer. 7:427–435. 2016.
View Article : Google Scholar :
|
|
109
|
Karamitopoulou E, Pallante P, Zlobec I,
Tornillo L, Carafa V, Schaffner T, Borner M, Diamantis I, Esposito
F, Brunner T, et al: Loss of the CBX7 protein expression correlates
with a more aggressive phenotype in pancreatic cancer. Eur J
Cancer. 46:1438–1444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zhu Y, Pu Z, Li Z, Lin Y, Li N and Peng F:
Comprehensive analysis of the expression and prognosis value of
chromobox family members in clear cell renal cell carcinoma. Front
Oncol. 11:7005282021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Hu K, Yao L, Xu Z, Yan Y and Li J:
Prognostic value and therapeutic potential of CBX family members in
ovarian cancer. Front Cell Dev Biol. 10:8323542022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Tian P, Zhang C, Ma C, Ding L, Tao N, Ning
L, Wang Y, Yong X, Yan Q, Lin X, et al: Decreased chromobox
homologue 7 expression is associated with epithelial-mesenchymal
transition and poor prognosis in cervical cancer. Open Med (Wars).
16:410–418. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Li D, Liu Y, Hao S, Chen B and Li A:
Mining database for the clinical significance and prognostic value
of CBX family in skin cutaneous melanoma. J Clin Lab Anal.
34:e235372020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Ning G, Huang YL, Zhen LM, Xu WX, Jiao Q,
Yang FJ, Wu LN, Zheng YY, Song J, Wang YS, et al: Transcriptional
expressions of Chromobox 1/2/3/6/8 as independent indicators for
survivals in hepatocellular carcinoma patients. Aging (Albany NY).
10:3450–3473. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Yang YF, Pan YH, Tian QH, Wu DC and Su SG:
CBX1 indicates poor outcomes and exerts oncogenic activity in
hepatocellular carcinoma. Transl Oncol. 11:1110–1118. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Zhong X, Kan A, Zhang W, Zhou J, Zhang H,
Chen J and Tang S: CBX3/HP1γ promotes tumor proliferation and
predicts poor survival in hepatocellular carcinoma. Aging (Albany
NY). 11:5483–5497. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zheng H, Jiang WH, Tian T, Tan HS, Chen Y,
Qiao GL, Han J, Huang SY, Yang Y, Li S, et al: CBX6 overexpression
contributes to tumor progression and is predictive of a poor
prognosis in hepatocellular carcinoma. Oncotarget. 8:18872–18884.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wang J, He H, Jiang Q, Wang Y and Jia S:
CBX6 promotes HCC metastasis via transcription factors
Snail/Zeb1-mediated EMT mechanism. Onco Targets Ther.
13:12489–12500. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhu X, Qin M, Li C, Zeng W, Bei C, Tan C,
Zhang Y, Shi W, Kong J, Fu Y, et al: Downregulated expression of
chromobox homolog 7 in hepatocellular carcinoma. Genet Test Mol
Biomarkers. 23:348–352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Tang B, Tian Y, Liao Y, Li Z, Yu S, Su H,
Zhong F, Yuan G, Wang Y, Yu H, et al: CBX8 exhibits oncogenic
properties and serves as a prognostic factor in hepatocellular
carcinoma. Cell Death Dis. 10:522019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zhang CZ, Chen SL, Wang CH, He YF, Yang X,
Xie D and Yun JP: CBX8 exhibits oncogenic activity via
AKT/β-catenin activation in hepatocellular carcinoma. Cancer Res.
78:51–63. 2018. View Article : Google Scholar
|
|
122
|
Pan C, Luo N, Guo K, Wang W, Li L, Fan N
and Tian Y: Members of the chromobox family have prognostic value
in hepatocellular carcinoma. Front Genet. 13:8879252022. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Xu Y, Pan S, Song Y, Pan C, Chen C and Zhu
X: The prognostic value of the chromobox family in human ovarian
cancer. J Cancer. 11:5198–5209. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Wheeler LJ, Watson ZL, Qamar L, Yamamoto
TM, Post MD, Berning AA, Spillman MA, Behbakht K and Bitler BG:
CBX2 identified as driver of anoikis escape and dissemination in
high grade serous ovarian cancer. Oncogenesis. 7:922018. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Yang Y, Hu Z, Sun H, Yu Q, Yang L, Yin F,
Sun Y, Pu L, Zhu X, Li S, et al: CBX7, a potential prognostic
biomarker in lung adenocarcinoma. Onco Targets Ther. 14:5477–5492.
2021. View Article : Google Scholar
|
|
126
|
Hu CY, Li X, Zeng T, Ye DM, Li YK and Yan
HX: Significance of chromobox protein (CBX) expression in diffuse
LBCL. Gene. 813:1460922022. View Article : Google Scholar
|
|
127
|
Tan C, Bei C, Zhu X, Zhang Y, Qin L and
Tan S: Single nucleotide polymorphisms of CBX4 and CBX7 decrease
the risk of hepatocellular carcinoma. Biomed Res Int.
2019:64368252019. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Zhu XY, Huang MJ, Su QY, Wang XZ, Wang J,
Long QQ, Wu XM, Huang XY, Yao JG and Long XD: The predictive
potential of genetic single nucleotide polymorphisms in CBX4 for
hepatocellular carcinoma survival. Front Biosci (Landmark Ed).
26:1191–1203. 2021. View
Article : Google Scholar : PubMed/NCBI
|
|
129
|
Chang C, Liu J, He W, Qu M, Huang X, Deng
Y, Shen L, Zhao X, Guo H, Jiang J, et al: A regulatory circuit
HP1γ/miR-451a/c-Myc promotes prostate cancer progression. Oncogene.
37:415–426. 2018. View Article : Google Scholar
|
|
130
|
Cheng W, Qi Y, Tian L, Wang B, Huang W and
Chen Y: Dicer promotes tumorigenesis by translocating to nucleus to
promote SFRP1 promoter methylation in cholangiocarcinoma cells.
Cell Death Dis. 8:e26282017. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Ci X, Hao J, Dong X, Choi SY, Xue H, Wu R,
Qu S, Gout PW, Zhang F, Haegert AM, et al: Heterochromatin protein
1α mediates development and aggressiveness of neuroendocrine
prostate cancer. Cancer Res. 78:2691–2704. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang X, Li L, Wu Y, Zhang R, Zhang M, Liao
D, Wang G, Qin G, Xu RH and Kang T: CBX4 suppresses metastasis via
recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma.
Cancer Res. 76:7277–7289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Jiang N, Niu G, Pan YH, Pan W, Zhang MF,
Zhang CZ and Shen H: CBX4 transcriptionally suppresses KLF6 via
interaction with HDAC1 to exert oncogenic activities in clear cell
renal cell carcinoma. EBioMedicine. 53:1026922020. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Yu T, Wu Y, Hu Q, Zhang J, Nie E, Wu W,
Wang X, Wang Y and Liu N: CBX7 is a glioma prognostic marker and
induces G1/S arrest via the silencing of CCNE1. Oncotarget.
8:26637–26647. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Federico A, Pallante P, Bianco M, Ferraro
A, Esposito F, Monti M, Cozzolino M, Keller S, Fedele M, Leone V,
et al: Chromobox protein homologue 7 protein, with decreased
expression in human carcinomas, positively regulates E-cadherin
expression by interacting with the histone deacetylase 2 protein.
Cancer Res. 69:7079–7087. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Wu Y, Duan Y, Li X, Zhao R, Lan B, Zhang
X, Wang X, Chen H, Feng S, Liu Z, et al: CBX8 together with SET
facilitates ovarian carcinoma growth and metastasis by suppressing
the transcription of SUSD2. Mol Cancer Res. 20:1611–1622. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Mancini M, Papon L, Mangé A, Cammas F and
Fabbrizio E: HP1s modulate the S-Adenosyl Methionine synthesis
pathway in liver cancer cells. Biochem J. 477:1033–1047. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Zhang K, Wang J, Yang L, Yuan YC, Tong TR,
Wu J, Yun X, Bonner M, Pangeni R, Liu Z, et al: Targeting histone
methyltransferase G9a inhibits growth and Wnt signaling pathway by
epigenetically regulating HP1α and APC2 gene expression in
non-small cell lung cancer. Mol Cancer. 17:1532018. View Article : Google Scholar
|
|
139
|
Zheng Q, Xu J, Lin Z, Lu Y, Xin X, Li X,
Yang Y, Meng Q, Wang C, Xiong W, et al: Inflammatory factor
receptor Toll-like receptor 4 controls telomeres through
heterochromatin protein 1 isoforms in liver cancer stem cell. J
Cell Mol Med. 22:3246–3258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Cheng W, Tian L, Wang B, Qi Y, Huang W, Li
H and Chen YJ: Downregulation of HP1α suppresses proliferation of
cholangiocarcinoma by restoring SFRP1 expression. Oncotarget.
7:48107–48119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Yi SA, Lee DH, Kim GW, Ryu HW, Park JW,
Lee J, Han J, Park JH, Oh H, Lee J, et al: HPV-mediated nuclear
export of HP1γ drives cervical tumorigenesis by downregulation of
p53. Cell Death Differ. 27:2537–2551. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Gao G, Wang L and Li C: Circ_0006790
carried by bone marrow mesenchymal stem cell-derived exosomes
regulates S100A11 DNA methylation through binding to CBX7 in
pancreatic ductal adenocarcinoma. Am J Cancer Res. 12:1934–1959.
2022.PubMed/NCBI
|
|
143
|
Zhang Z, Li N, Wei X, Chen B, Zhang Y,
Zhao Y, Hu X and Hou S: GRM4 inhibits the proliferation, migration,
and invasion of human osteosarcoma cells through interaction with
CBX4. Biosci Biotechnol Biochem. 84:279–289. 2020. View Article : Google Scholar
|
|
144
|
Wang W, Li X, Guan C, Hu Z, Zhao Y, Li W
and Jiang X: LncRNA PCAT6 promotes the proliferation, migration and
invasion of pancreatic ductal adenocarcinoma via regulating
miR-185-5p/CBX2 axis. Pathol Res Pract. 216:1530742020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Huo W, Tan D and Chen Q: CASC9 facilitates
cell proliferation in bladder cancer by regulating CBX2 expression.
Nephron. 144:388–399. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Mather RL, Parolia A, Carson SE,
Venalainen E, Roig-Carles D, Jaber M, Chu SC, Alborelli I, Wu R,
Lin D, et al: The evolutionarily conserved long non-coding RNA
LINC00261 drives neuroendocrine prostate cancer proliferation and
metastasis via distinct nuclear and cytoplasmic mechanisms. Mol
Oncol. 15:1921–1941. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Dou Y, Chen F, Lu Y, Qiu H and Zhang H:
Effects of Wnt/β-catenin signal pathway regulated by miR-342-5p
targeting CBX2 on proliferation, metastasis and invasion of ovarian
cancer cells. Cancer Manag Res. 12:3783–3794. 2020. View Article : Google Scholar :
|
|
148
|
Han Q, Li C, Cao Y, Bao J, Li K, Song R,
Chen X, Li J and Wu X: CBX2 is a functional target of miRNA let-7a
and acts as a tumor promoter in osteosarcoma. Cancer Med.
8:3981–3991. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Zhu J, Luo JE, Chen Y and Wu Q:
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX
sensitivity by regulating miR-136/CBX2 axis in ovarian cancer. J
Ovarian Res. 14:1362021. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wang F, Zhang L, Luo Y, Zhang Q, Zhang Y,
Shao Y and Yuan L: The LncRNA RP11-279C4.1 enhances the malignant
behaviour of glioma cells and glioma stem-like cells by regulating
the miR-1273g-3p/CBX3 axis. Mol Neurobiol. 58:3362–3373. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Zhou W, Li H, Shang S and Liu F: lncRNA
KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular
carcinoma progression via regulating the miR-29a-3p/CBX3 axis. Braz
J Med Biol Res. 54:e102132021. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Song Y, Wang S and Cheng X: LINC01006
regulates the proliferation, migration and invasion of
hepatocellular carcinoma cells through regulating miR-433-3p/CBX3
axis. Ann Hepatol. 25:1003432021. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Liu J, Zhan Y, Wang J, Wang J, Guo J and
Kong D: lncRNA-SNHG17 promotes colon adenocarcinoma progression and
serves as a sponge for miR-375 to regulate CBX3 expression. Am J
Transl Res. 12:5283–5295. 2020.PubMed/NCBI
|
|
154
|
Huang Y, Lin Y, Song X and Wu D: LINC00857
contributes to proliferation and lymphomagenesis by regulating
miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
Carcinogenesis. 42:733–741. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J,
Chen F, Xi S and Chen Z: LncRNA LINC00998 inhibits the malignant
glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell
Death Dis. 11:10322020. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Zhang P, Yang X, Zha Z, Zhu Y, Zhang G and
Li G: CBX3 regulated by miR-139 promotes the development of HCC by
regulating cell cycle progression. Cell Cycle. 21:1740–1752. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Liu M, Huang F, Zhang D, Ju J, Wu XB, Wang
Y, Wang Y, Wu Y, Nie M, Li Z, et al: Heterochromatin protein HP1γ
promotes colorectal cancer progression and is regulated by miR-30a.
Cancer Res. 75:4593–4604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Gao F, Du Y, Zhang Y, Ren D, Xu J and Chen
D: Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth
and invasion in glioma through miR-1265 sponge activity. Gene.
726:1441962020. View Article : Google Scholar
|
|
159
|
Kang S, Ou C, Yan A, Zhu K, Xue R, Zhang Y
and Lai J: Long Noncoding RNA SNHG5 induces the NF-κB pathway by
regulating miR-181c-5p/CBX4 axis to promote the progression of
Non-small cell lung cancer. Arch Bronconeumol. 59:10–18. 2022.
View Article : Google Scholar
|
|
160
|
Yang Z, OuYang X, Zheng L, Dai L and Luo
W: Long intergenic noncoding RNA00265 promotes proliferation of
gastric cancer via the microRNA-144-3p/Chromobox 4 axis.
Bioengineered. 12:1012–1025. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Zhao J, Yang T and Li L: LncRNA FOXP4-AS1
is involved in cervical cancer progression via regulating
miR-136-5p/CBX4 Axis. Onco Targets Ther. 13:2347–2355. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Zheng Z, Qiu K and Huang W: Long
Non-coding RNA (lncRNA) RAMS11 promotes metastatis and cell growth
of prostate cancer by CBX4 complex binding to Top2α. Cancer Manag
Res. 13:913–923. 2021. View Article : Google Scholar :
|
|
163
|
Meng R, Fang J, Yu Y, Hou LK, Chi JR, Chen
AX, Zhao Y and Cao XC: miR-129-5p suppresses breast cancer
proliferation by targeting CBX4. Neoplasma. 65:572–578. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Wen LJ, Wang YS and Tan PY: miR-515-5p
inhibits the proliferation, migration and invasion of human breast
cancer cells by targeting CBX4. Exp Ther Med. 22:13282021.
View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Fang X and Pan A: MiR-507 inhibits the
progression of gastric carcinoma via targeting CBX4-mediated
activation of Wnt/β-catenin and HIF-1α pathways. Clin Transl Oncol.
24:2021–2028. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Dou Z, Lu F, Hu J, Wang H, Li B and Li X:
MicroRNA-6838-5p suppresses the self-renewal and metastasis of
human liver cancer stem cells through downregulating CBX4
expression and inactivating ERK signaling. Biol Chem. 404:29–39.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Chen Y, Du J, Wang Y, Shi H, Jiang Q, Wang
Y, Zhang H, Wei Y, Xue W, Pu Z, et al: MicroRNA-497-5p induces cell
cycle arrest of cervical cancer cells in S phase by targeting CBX4.
Onco Targets Ther. 12:10535–10545. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yan X, Kang D, Lin Y, Qi S and Jiang C:
CBX4-dependent regulation of HDAC3 nuclear translocation reduces
Bmp2-induced osteoblastic differentiation and calcification in
adamantinomatous craniopharyngioma. Cell Commun Signal. 20:32022.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Zhao W, Ma B, Tian Z, Han H, Tang J, Dong
B, An G, Cao B and Wang B: Inhibiting CBX4 efficiently protects
hepatocellular carcinoma cells against sorafenib resistance. Br J
Cancer. 124:1237–1248. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Yu F, Lin Y, Ai MM, Tan GJ, Huang JL and
Zou ZR: Knockdown of circular RNA hsa_circ_PVT1 inhibited laryngeal
cancer progression via preventing wnt4/β-catenin signaling pathway
activation. Front Cell Dev Biol. 9:6581152021. View Article : Google Scholar
|
|
171
|
Huang FJ, Dang JQ, Zhang S and Cheng ZY:
Circular RNA hsa_ circ_0008039 promotes proliferation, migration
and invasion of breast cancer cells through upregulating CBX4 via
sponging miR-515-5p. Eur Rev Med Pharmacol Sci. 24:1887–1898.
2020.PubMed/NCBI
|
|
172
|
Sun Y, Wang X and Bu X: LINC02381
contributes to cell proliferation and hinders cell apoptosis in
glioma by transcriptionally enhancing CBX5. Brain Res Bull.
176:121–129. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Yu L, Zhang W, Wang P, Zhang Q, Cong A,
Yang X and Sang K: LncRNA SNHG11 aggravates cell proliferation and
migration in triple-negative breast cancer via sponging miR-2355-5p
and targeting CBX5. Exp Ther Med. 22:8922021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Li H, Li J, Jia S, Wu M, An J, Zheng Q,
Zhang W and Lu D: miR675 upregulates long noncoding RNA H19 through
activating EGR1 in human liver cancer. Oncotarget. 6:31958–31984.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Yang Y, Meng Q, Wang C, Li X, Lu Y, Xin X,
Zheng Q and Lu D: MicroRNA 675 cooperates PKM2 to aggravate
progression of human liver cancer stem cells induced from embryonic
stem cells. J Mol Med (Berl). 96:1119–1130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Wu C and Zhang J: Long non-conding RNA
LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in
renal cell carcinoma. Biosci Rep. 40:BSR202002122020. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Shi X, Song S, Gao Y, Cui Z, Wang W and
Liu M: Circ_0037866 contributes to the tumorigenesis of renal cell
carcinoma by sequestering miR-384 to elevate chromobox 5
expression. Kidney Blood Press Res. 47:329–340. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Li F, Sun X, Liu Q, Liu X and Zhang J:
Long Noncoding RNA MIR100HG knockdown attenuates hepatocellular
carcinoma progression by regulating MicroRNA-146b-5p/Chromobox 6.
Gastroenterol Res Pract. 2021:68325182021. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Pei YF, He Y, Hu LZ, Zhou B, Xu HY and Liu
XQ: The Crosstalk between lncRNA-SNHG7/miRNA-181/cbx7 modulates
malignant character in lung adenocarcinoma. Am J Pathol.
190:1343–1354. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Peng X, Guan L and Gao B: miRNA-19
promotes non-small-cell lung cancer cell proliferation via
inhibiting CBX7 expression. Onco Targets Ther. 11:8865–8874. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Xie D, Shang C, Zhang H, Guo Y and Tong X:
Up-regulation of miR-9 target CBX7 to regulate invasion ability of
bladder transitional cell carcinoma. Med Sci Monit. 21:225–230.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Pickl JM, Tichy D, Kuryshev VY, Tolstov Y,
Falkenstein M, Schüler J, Reidenbach D, Hotz-Wagenblatt A,
Kristiansen G, Roth W, et al: Ago-RIP-Seq identifies Polycomb
repressive complex I member CBX7 as a major target of miR-375 in
prostate cancer progression. Oncotarget. 7:59589–59603. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Zhao Y, Liu XL, Huang JH, Yin AJ and Zhang
H: MicroRNA-18a suppresses ovarian carcinoma progression by
targeting CBX7 and regulating ERK/MAPK signaling pathway and
epithelial-to-mesenchymal transition. Eur Rev Med Pharmacol Sci.
24:5292–5302. 2020.PubMed/NCBI
|
|
184
|
Mansueto G, Forzati F, Ferraro A, Pallante
P, Bianco M, Esposito F, Iaccarino A, Troncone G and Fusco A:
Identification of a new pathway for tumor progression:
MicroRNA-181b Up-regulation and CBX7 Down-regulation by HMGA1
Protein. Genes Cancer. 1:210–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Gong L, Tang Y, Jiang L, Tang W and Luo S:
Regulation of circGOLPH3 and its binding protein CBX7 on the
proliferation and apoptosis of prostate cancer cells. Biosci Rep.
40:BSR202009362020. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Song X, Ning W, Niu J, Zhang G, Liu H and
Zhou L: CBX8 acts as an independent RNA-binding protein to regulate
the maturation of miR-378a-3p in colon cancer cells. Hum Cell.
34:515–529. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Liang Y, Yu ZJ, Liu M, Liu HM, Zhang JZ,
Xiong T, Tang YY and Huang ZP: hsa-miR-429 targets CBX8 to promote
cell apoptosis in diffuse large B-cell lymphoma. Mol Med Rep.
24:8572021. View Article : Google Scholar :
|
|
188
|
Xu Y, Yao Y, Leng K, Ji D, Qu L, Liu Y and
Cui Y: Increased expression of circular RNA circ_0005230 indicates
dismal prognosis in breast cancer and regulates cell proliferation
and invasion via miR-618/CBX8 signal pathway. Cell Physiol Biochem.
51:1710–1722. 2018. View Article : Google Scholar
|
|
189
|
Liu J, Wang D, Long Z, Liu J and Li W:
CircRNA8924 promotes cervical cancer cell proliferation, migration
and invasion by competitively binding to MiR-518d-5p/519-5p family
and modulating the expression of CBX8. Cell Physiol Biochem.
48:173–184. 2018. View Article : Google Scholar
|
|
190
|
Yi SA, Ryu HW, Lee DH, Han JW and Kwon SH:
HP1β suppresses metastasis of human cancer cells by decreasing the
expression and activation of MMP2. Int J Oncol. 45:2541–2548. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Clermont PL, Crea F, Chiang YT, Lin D,
Zhang A, Wang JZ, Parolia A, Wu R, Xue H, Wang Y, et al:
Identification of the epigenetic reader CBX2 as a potential drug
target in advanced prostate cancer. Clin Epigenetics. 8:162016.
View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Alam H, Li N, Dhar SS, Wu SJ, Lv J, Chen
K, Flores ER, Baseler L and Lee MG: HP1γ promotes lung
adenocarcinoma by downregulating the transcription-repressive
regulators NCOR2 and ZBTB7A. Cancer Res. 78:3834–3848. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Fan Y, Li H, Liang X and Xiang Z: CBX3
promotes colon cancer cell proliferation by CDK6 kinase-independent
function during cell cycle. Oncotarget. 8:19934–19946. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Chen LY, Cheng CS, Qu C, Wang P, Chen H,
Meng ZQ and Chen Z: Overexpression of CBX3 in pancreatic
adenocarcinoma promotes cell cycle transition-associated tumor
progression. Int J Mol Sci. 19:17682018. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Zhang H, Yu H, Ren D, Sun Y, Guo F, Cai H,
Zhou C, Zhou Y, Jin X and Wu H: CBX3 regulated By YBX1 promotes
smoking-induced pancreatic cancer progression via inhibiting SMURF2
expression. Int J Biol Sci. 18:3484–3497. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Sanyal S, Mondal P, Sen S, Sengupta
Bandyopadhyay S and Das C: SUMO E3 ligase CBX4 regulates
hTERT-mediated transcription of CDH1 and promotes breast cancer
cell migration and invasion. Biochem J. 477:3803–3818. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Hu C, Zhang Q, Tang Q, Zhou H, Liu W,
Huang J, Liu Y, Wang Q, Zhang J, Zhou M, et al: CBX4 promotes the
proliferation and metastasis via regulating BMI-1 in lung cancer. J
Cell Mol Med. 24:618–631. 2020. View Article : Google Scholar
|
|
198
|
Wang X, Qin G, Liang X, Wang W, Wang Z,
Liao D, Zhong L, Zhang R, Zeng YX, Wu Y, et al: Targeting the
CK1α/CBX4 axis for metastasis in osteosarcoma. Nat Commun.
11:11412020. View Article : Google Scholar
|
|
199
|
Thomsen R, Christensen DB, Rosborg S,
Linnet TE, Blechingberg J and Nielsen AL: Analysis of HP1α
regulation in human breast cancer cells. Mol Carcinog. 50:601–613.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Prieto C, Nguyen D, Liu Z, Wheat J, Perez
A, Gourkanti S, Chou T, Barin E, Velleca A, Rohwetter T, et al:
Transcriptional control of CBX5 by the RNA binding proteins RBMX
and RBMXL1 maintains chromatin state in myeloid leukemia. Nat
Cancer. 2:741–757. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Deng H, Guan X, Gong L, Zeng J, Zhang H,
Chen MY and Li G: CBX6 is negatively regulated by EZH2 and plays a
potential tumor suppressor role in breast cancer. Sci Rep.
9:1972019. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Sakai K, Nishiuchi T, Tange S, Suzuki Y,
Yano S, Terashima M, Suzuki T and Matsumoto K: Proteasomal
degradation of polycomb-group protein CBX6 confers MMP-2 expression
essential for mesothelioma invasion. Sci Rep. 10:166782020.
View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Wu W, Zhou X, Yu T, Bao Z, Zhi T, Jiang K,
Nie E, Wang Y, Zhang J and You Y: The malignancy of miR-18a in
human glioblastoma via directly targeting CBX7. Am J Cancer Res.
7:64–76. 2017.PubMed/NCBI
|
|
204
|
Bao Z, Xu X, Liu Y, Chao H, Lin C, Li Z,
You Y, Liu N and Ji J: CBX7 negatively regulates migration and
invasion in glioma via Wnt/β-catenin pathway inactivation.
Oncotarget. 8:39048–39063. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Dai T, Liu Y, Cao R and Cao J: CBX7
regulates metastasis of basal-like breast cancer through
Twist1/EphA2 pathway. Transl Oncol. 24:1014682022. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Bernard D, Martinez-Leal JF, Rizzo S,
Martinez D, Hudson D, Visakorpi T, Peters G, Carnero A, Beach D and
Gil J: CBX7 controls the growth of normal and tumor-derived
prostate cells by repressing the Ink4a/Arf locus. Oncogene.
24:5543–5551. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Huang Z, Liu J, Yang J, Yan Y, Yang C, He
X, Huang R, Tan M, Wu D, Yan J, et al: PDE4B Induces
Epithelial-to-mesenchymal transition in bladder cancer cells and is
transcriptionally suppressed by CBX7. Front Cell Dev Biol.
9:7830502021. View Article : Google Scholar :
|
|
208
|
Jia Y, Wang Y, Zhang C and Chen MY:
Upregulated CBX8 promotes cancer metastasis via the WNK2/MMP2
pathway. Mol Ther Oncolytics. 19:188–196. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Wang G, Tang J, Zhan W, Zhang R, Zhang M,
Liao D, Wang X, Wu Y and Kang T: CBX8 suppresses tumor metastasis
via repressing snail in esophageal squamous cell carcinoma.
Theranostics. 7:3478–3488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Yang S, Liu W, Li M, Wen J, Zhu M and Xu
S: Insulin-like growth Factor-1 modulates polycomb Cbx8 expression
and inhibits colon cancer cell apoptosis. Cell Biochem Biophys.
71:1503–1507. 2015. View Article : Google Scholar
|
|
211
|
Tan J, Jones M, Koseki H, Nakayama M,
Muntean AG, Maillard I and Hess JL: CBX8, a polycomb group protein,
is essential for MLL-AF9-induced leukemogenesis. Cancer Cell.
20:563–575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Mao J, Tian Y, Wang C, Jiang K, Li R, Yao
Y, Zhang R, Sun D, Liang R, Gao Z, et al: CBX2 regulates
proliferation and apoptosis via the phosphorylation of YAP in
hepatocellular carcinoma. J Cancer. 10:2706–2719. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Peng W, Shi S, Zhong J, Liang H, Hou J, Hu
X, Wang F, Zhang J, Geng S, Sun X, et al: CBX3 accelerates the
malignant progression of glioblastoma multiforme by stabilizing
EGFR expression. Oncogene. 41:3051–3063. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Li J, Xu Y, Long XD, Wang W, Jiao HK, Mei
Z, Yin QQ, Ma LN, Zhou AW, Wang LS, et al: Cbx4 governs HIF-1α to
potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3
ligase activity. Cancer Cell. 25:118–131. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Bawa-Khalfe T, Lu LS, Zuo Y, Huang C, Dere
R, Lin FM and Yeh ET: Differential expression of SUMO-specific
protease 7 variants regulates epithelial-mesenchymal transition.
Proc Natl Acad Sci USA. 109:17466–17471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Lin FM, Kumar S, Ren J, Karami S, Bahnassy
S, Li Y, Zheng X, Wang J and Bawa-Khalfe T: SUMOylation of HP1α
supports association with ncRNA to define responsiveness of breast
cancer cells to chemotherapy. Oncotarget. 7:30336–30349. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Shiota M, Song Y, Yokomizo A, Tada Y,
Kuroiwa K, Eto M, Oda Y, Inokuchi J, Uchiumi T, Fujimoto N, et al:
Human heterochromatin protein 1 isoform HP1beta enhances androgen
receptor activity and is implicated in prostate cancer growth.
Endocr Relat Cancer. 17:455–467. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Hu FF, Chen H, Duan Y, Lan B, Liu CJ, Hu
H, Dong X, Zhang Q, Cheng YM, Liu M, et al: CBX2 and EZH2
cooperatively promote the growth and metastasis of lung
adenocarcinoma. Mol Ther Nucleic Acids. 27:670–684. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Li J, Alvero AB, Nuti S, Tedja R, Roberts
CM, Pitruzzello M, Li Y, Xiao Q, Zhang S, Gan Y, et al: CBX7 binds
the E-box to inhibit TWIST-1 function and inhibit tumorigenicity
and metastatic potential. Oncogene. 39:3965–3979. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Xiao L, Zhou Z, Li W, Peng J, Sun Q, Zhu
H, Song Y, Hou JL, Sun J, Cao HC, et al: Chromobox homolog 8 (CBX8)
Interacts with Y-Box binding protein 1 (YBX1) to promote cellular
proliferation in hepatocellular carcinoma cells. Aging (Albany NY).
11:7123–7149. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Zeng F, Luo L, Li D, Guo J and Guo M:
KPNA2 interaction with CBX8 contributes to the development and
progression of bladder cancer by mediating the PRDM1/c-FOS pathway.
J Transl Med. 19:1122021. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Bilton LJ, Warren C, Humphries RM, Kalsi
S, Waters E, Francis T, Dobrowinski W, Beltran-Alvarez P and Wade
MA: The epigenetic regulatory protein CBX2 promotes mTORC1
signalling and inhibits DREAM complex activity to drive breast
cancer cell growth. Cancers (Basel). 14:34912022. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Zeng M, Li B, Yang L and Guan Q: CBX2
depletion inhibits the proliferation, invasion and migration of
gastric cancer cells by inactivating the YAP/β-catenin pathway. Mol
Med Rep. 23:1372021. View Article : Google Scholar
|
|
224
|
Wang L, Ren B, Zhuang H, Zhong Y and Nan
Y: CBX2 induces glioma cell proliferation and invasion through the
Akt/PI3K pathway. Technol Cancer Res Treat.
20:153303382110458312021. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Jin X, Zhang B, Zhang H and Yu H:
Smoking-associated upregulation of CBX3 suppresses ARHGAP24
expression to activate Rac1 signaling and promote tumor progression
in lung adenocarcinoma. Oncogene. 41:538–549. 2022. View Article : Google Scholar :
|
|
226
|
Nawaz Z, Patil V, Arora A, Hegde AS,
Arivazhagan A, Santosh V and Somasundaram K: Cbx7 is epigenetically
silenced in glioblastoma and inhibits cell migration by targeting
YAP/TAZ-dependent transcription. Sci Rep. 6:277532016. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Kim HY, Park JH, Won HY, Lee JY and Kong
G: CBX7 inhibits breast tumorigenicity through DKK-1-mediated
suppression of the Wnt/β-catenin pathway. FASEB J. 29:300–313.
2015. View Article : Google Scholar
|
|
228
|
Ni S, Wang H, Zhu X, Wan C, Xu J, Lu C,
Xiao L, He J, Jiang C, Wang W, et al: CBX7 suppresses cell
proliferation, migration, and invasion through the inhibition of
PTEN/Akt signaling in pancreatic cancer. Oncotarget. 8:8010–8021.
2017. View Article : Google Scholar :
|
|
229
|
Ni SJ, Zhao LQ, Wang XF, Wu ZH, Hua RX,
Wan CH, Zhang JY, Zhang XW, Huang MZ, Gan L, et al: CBX7 regulates
stem cell-like properties of gastric cancer cells via p16 and
AKT-NF-κB-miR-21 pathways. J Hematol Oncol. 11:172018. View Article : Google Scholar
|
|
230
|
Zhang XW, Zhang L, Qin W, Yao XH, Zheng
LZ, Liu X, Li J and Guo WJ: Oncogenic role of the chromobox protein
CBX7 in gastric cancer. J Exp Clin Cancer Res. 29:1142010.
View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Chen LY, Cheng CS, Qu C, Wang P, Chen H,
Meng ZQ and Chen Z: CBX3 promotes proliferation and regulates
glycolysis via suppressing FBP1 in pancreatic cancer. Biochem
Biophys Res Commun. 500:691–697. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Di Costanzo A, Del Gaudio N, Conte L,
Dell'Aversana C, Vermeulen M, de Thé H, Migliaccio A, Nebbioso A
and Altucci L: The HDAC inhibitor SAHA regulates CBX2 stability via
a SUMO-triggered ubiquitin-mediated pathway in leukemia. Oncogene.
37:2559–2572. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Yi SA, Kim GW, Yoo J, Han JW and Kwon SH:
HP1γ sensitizes cervical cancer cells to Cisplatin through the
Suppression of UBE2L3. Int J Mol Sci. 21:59762020. View Article : Google Scholar
|
|
234
|
Silva-Fisher JM, Dang HX, White NM, Strand
MS, Krasnick BA, Rozycki EB, Jeffers G, Grossman JG, Highkin MK,
Tang C, et al: Long non-coding RNA RAMS11 promotes metastatic
colorectal cancer progression. Nat Commun. 11:21562020. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Oliva J, El Messaoudi S, Pellestor F,
Fuentes M, Georget V, Balaguer P, Cavaillès V, Vignon F and Badia
E: Involvement of HP1alpha protein in irreversible transcriptional
inactivation by antiestrogens in breast cancer cells. FEBS Lett.
579:4278–4286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Chen L, Xia JS, Wu JH, Chen YG and Qiu CJ:
Resveratrol inhibits oral squamous cell carcinoma cells
proliferation while promoting apoptosis through inhibition of CBX7
protein. Environ Toxicol. 35:1234–1240. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Cacciola NA, Sepe R, Forzati F, Federico
A, Pellecchia S, Malapelle U, De Stefano A, Rocco D, Fusco A and
Pallante P: Restoration of CBX7 expression increases the
susceptibility of human lung carcinoma cells to irinotecan
treatment. Naunyn Schmiedebergs Arch Pharmacol. 388:1179–1186.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Liu W, Wang H, Jian C, Li W, Ye K, Ren J,
Zhu L, Wang Y, Jin X and Yi L: The RNF26/CBX7 axis modulates the
TNF pathway to promote cell proliferation and regulate sensitivity
to TKIs in ccRCC. Int J Biol Sci. 18:2132–2145. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Lee SH, Um SJ and Kim EJ: CBX8 antagonizes
the effect of Sirtinol on premature senescence through the
AKT-RB-E2F1 pathway in K562 leukemia cells. Biochem Biophys Res
Commun. 469:884–890. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Wang S, Alpsoy A, Sood S, Ordonez-Rubiano
SC, Dhiman A, Sun Y, Jiao G, Krusemark CJ and Dykhuizen EC: A
potent, selective CBX2 Chromodomain ligand and its cellular
activity during prostate cancer neuroendocrine differentiation.
Chembiochem. 22:2335–2344. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Stuckey JI, Dickson BM, Cheng N, Liu Y,
Norris JL, Cholensky SH, Tempel W, Qin S, Huber KG, Sagum C, et al:
A cellular chemical probe targeting the chromodomains of Polycomb
repressive complex 1. Nat Chem Biol. 12:180–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Liu H, Li Z and Li L: The molecular
selectivity of UNC3866 inhibitor for Polycomb CBX7 protein from
molecular dynamics simulation. Comput Biol Chem. 74:339–346. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Milosevich N, Gignac MC, McFarlane J,
Simhadri C, Horvath S, Daze KD, Croft CS, Dheri A, Quon TT, Douglas
SF, et al: Selective inhibition of CBX6: A methyllysine reader
protein in the polycomb family. ACS Med Chem Lett. 7:139–144. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Milosevich N, Wilson CR, Brown TM, Alpsoy
A, Wang S, Connelly KE, Sinclair K, Ponio FR, Hof R, Dykhuizen EC,
et al: Polycomb Paralog Chromodomain inhibitors active against both
CBX6 and CBX8*. ChemMedChem. 16:3027–3034. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Ren C, Morohashi K, Plotnikov AN, Jakoncic
J, Smith SG, Li J, Zeng L, Rodriguez Y, Stojanoff V, Walsh M, et
al: Small-molecule modulators of methyl-lysine binding for the CBX7
chromodomain. Chem Biol. 22:161–168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Connelly KE, Martin EC and Dykhuizen EC:
CBX Chromodomain inhibition enhances chemotherapy response in
glioblastoma multiforme. Yale J Biol Med. 89:431–440.
2016.PubMed/NCBI
|
|
247
|
Simhadri C, Gignac MC, Anderson CJ,
Milosevich N, Dheri A, Prashar N, Flemmer RT, Dev A, Henderson TG,
Douglas SF, et al: Structure-activity relationships of Cbx7
inhibitors, including selectivity studies against other Cbx
proteins. ACS Omega. 1:541–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Ren C, Smith SG, Yap K, Li S, Li J, Mezei
M, Rodriguez Y, Vincek A, Aguilo F, Walsh MJ, et al:
Structure-guided discovery of selective antagonists for the
chromodomain of polycomb repressive protein CBX7. ACS Med Chem
Lett. 7:601–605. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Lamb KN, Bsteh D, Dishman SN, Moussa HF,
Fan H, Stuckey JI, Norris JL, Cholensky SH, Li D, Wang J, et al:
Discovery and characterization of a cellular potent positive
allosteric modulator of the polycomb repressive Complex 1
chromodomain, CBX7. Cell Chem Biol. 26:1365–1379.e22. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Simhadri C, Daze KD, Douglas SF,
Milosevich N, Monjas L, Dev A, Brown TM, Hirsch A, Wulff JE and Hof
F: Rational adaptation of L3MBTL1 inhibitors to create
small-molecule Cbx7 antagonists. ChemMedChem. 14:1444–1456. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Denton KE, Wang S, Gignac MC, Milosevich
N, Hof F, Dykhuizen EC and Krusemark CJ: Robustness of in vitro
selection assays of DNA-encoded peptidomimetic ligands to CBX7 and
CBX8. SLAS Discov. 23:417–428. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Suh JL, Bsteh D, Hart B, Si Y, Weaver TM,
Pribitzer C, Lau R, Soni S, Ogana H, Rectenwald JM, et al:
Reprogramming CBX8-PRC1 function with a positive allosteric
modulator. Cell Chem Biol. 29:555–571.e11. 2022. View Article : Google Scholar :
|
